The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Annovis Bio, Inc(NYSE:ANVS)


Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chron...
Website: http://www.qrpharma.com
Founded: 2008
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Annovis Bio Op Cashflow Per Share ttm
Annovis Bio Free Cashflow Per Share ttm
Annovis Bio Cash Per Share ttm
Annovis Bio (GAAP) P/E ratio ttm
Annovis Bio P/B ratio ttm
No extra charts and metrics for this ticker.